Research News and Research

RSS

New technology developed to rapidly identify compounds for the treatment of heart failure

Research conducted by University of Minnesota scientists, in collaboration with Celladon Corporation, has led to the invention of technology to more rapidly identify compounds for the treatment of heart failure.

24 Nov 2009

Seattle Genetics and Agensys expand ADC collaboration

Seattle Genetics, Inc. (Nasdaq: SGEN) and Agensys, Inc., an affiliate of Astellas, announced today an expansion of the companies’ antibody-drug conjugate (ADC) collaboration. Under the amended agreement, Agensys will pay a $12 million fee for exclusive rights to ADC licenses against additional antigen targets. Seattle Genetics also receives an option to co-develop another ADC at the time of investigational new drug (IND) submission.

24 Nov 2009

Breast cancer patients treated with chemotherapy drug Taxol more likely to develop chronic neuropathic pain

Breast cancer patients treated with the chemotherapy drug Taxol (paclitaxel) are more likely to develop chronic neuropathic pain, according to research published in The Journal of Pain, the peer review publication of the American Pain Society.

24 Nov 2009

Researchers find causes for patellofemoral pain syndrome

From professional athletes to weekend warriors, the condition known as "runner's knee" is a painful and potentially debilitating injury suffered by millions of people - although until now, it has been unclear just what causes it.

24 Nov 2009

Exposure to gas fumes can increase aggressive behavior

Outrageous prices may not be the only thing causing anger at the petrol pumps. A new study, published in the open access journal BMC Physiology, has shown that rats exposed to fumes from leaded and unleaded gasoline become more aggressive.

24 Nov 2009

NIGMS invests $42.3 million in "Grand Opportunities" grant

The National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH), is investing $42.3 million for grants in scientific areas it identified as "Grand Opportunities (GO)." NIH developed the GO grant program to stimulate biomedical research and the economy using funds provided by the American Recovery and Reinvestment Act (Recovery Act).

24 Nov 2009

Burnout and depression may contribute to major medical errors, says new study

Major medical errors self-reported by American surgeons are strongly related to both burnout and depression. Those findings appear today in the online edition of Annals of Surgery. The Mayo Clinic-led study included collaborators from Johns Hopkins and the American College of Surgeons.

24 Nov 2009

Lysteda tablets to treat menorrhagia approved by the FDA

The U.S. Food and Drug Administration today approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot.

24 Nov 2009

Treatment rates for hepatitis C virus declining, say researchers

Researchers from the University of Michigan determined that only 663,000 of the approximately 3.9 million Americans with hepatitis C virus (HCV) infection received antiviral therapy between 2002 and 2007.

24 Nov 2009

USC University Hospital receives Heart Transplant Excellence Award

The University of Southern California (USC) University Hospital received a Heart Transplant Excellence Award from the independent healthcare ratings organization Health Grades, ranking among the top one percent of hospitals in the U.S. that perform heart transplants.

24 Nov 2009

Human-derived UCB stem cell transplant has positive therapeutic effects on specific lung and heart disorders

Two separate studies published in the current issue of Cell Transplantation (18:8), - now freely available on-line at http://www.ingentaconnect.com/content/cog/ct - have shown that transplanted human-derived umbilical cord blood (UCB) stem cells transplanted in an animal model had positive therapeutic effects on specific lung and heart disorders the animal models.

24 Nov 2009

Study: Impaired oxidation in liver associated with progression to nonalcoholic steatohepatitis

A recent metobolomics study by researchers from Virginia Commonwealth University Medical Center in Richmond found that impaired peroxisomal oxidation of polyunsaturated fatty acids (PUFA) is associated with the progression of nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH).

24 Nov 2009

Health Heritage: New website for maintaining family's health history

A team of researchers at the University of Virginia received funding from the National Cancer Institute, an agency of the National Institutes of Health, to enhance a Web site called Health Heritage®. This site will enable family members to enter their family medical histories so that other family members and their health care professionals can use this information while dealing with medical issues.

24 Nov 2009

Misconceptions about contraception contribute to lack of family-planning n Uganda

University of Alberta graduate student Jennifer Heys wants to make her message clear: there needs to be more education in Ugandan communities about contraception.

24 Nov 2009

DTCA linked with increased Medicaid pharmacy expenditures

Direct-to-consumer advertising (DTCA) for a commonly prescribed antiplatelet drug does not appear associated with increased use, but may be associated with increased drug costs and Medicaid pharmacy expenditures, according to a report in the November 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

24 Nov 2009

Press Ganey releases 'Patient Perspectives on American Health Care' report

Press Ganey Associates, Inc. released today the 2009 Hospital Pulse Report: Patient Perspectives on American Health Care. The report examines patient satisfaction across the country; trends in overall patient perceptions; and variations based on metropolitan areas, services provided within the hospital, hospital size, and patient age.

24 Nov 2009

Jubilant Organosys, UAB and Southern Research Institute announce joint venture to accelerate global drug development

Jubilant Organosys, the University of Alabama at Birmingham (UAB), and Southern Research Institute today announced a joint venture that will focus on leveraging their collective innovation and enabling technologies in the areas of Oncology, Metabolic Disease and Infectious Diseases. It is a unique U.S.-India arbitraged and leveraged partnership that will accelerate the development of affordable therapies for patients worldwide.

24 Nov 2009

Urban sprawl causes delay in ambulances reaching their destinations in the United States

Previous research has demonstrated links between urban sprawl and many of our most pressing public health issues, including obesity and traffic injuries. New research from the University of Virginia Health System shows that urban sprawl also causes delays in ambulances reaching their destinations in sprawling sections of large metropolitan areas in the United States. The study appears in the November edition of the American Journal of Preventive Medicine.

24 Nov 2009

AmKor and Hengdian Group sign license agreement to develop and market new drug candidate in China

AmKor (AmKor Pharma, Inc.) and Hengdian Group (Hengdian Group Ltd) today announced the signing of licensing agreement for further development and commercialization of Neu2000 in China.

24 Nov 2009

10 x '20 Initiative calls for global commitment to develop 10 new antibiotics by 2020

The Infectious Diseases Society of America (IDSA) has asked for a commitment from the Obama administration and the European Union to further the Society's mission to achieve the development of 10 new antibiotics within the next 10 years, known as the 10 x '20 Initiative. The World Health Organization (WHO) has identified antimicrobial resistance as one of the three greatest threats to human health.

24 Nov 2009

Research News and Research

New technology developed to rapidly identify compounds for the treatment of heart failure

Seattle Genetics and Agensys expand ADC collaboration

Breast cancer patients treated with chemotherapy drug Taxol more likely to develop chronic neuropathic pain

Researchers find causes for patellofemoral pain syndrome

Exposure to gas fumes can increase aggressive behavior

NIGMS invests $42.3 million in "Grand Opportunities" grant

Burnout and depression may contribute to major medical errors, says new study

Lysteda tablets to treat menorrhagia approved by the FDA

Treatment rates for hepatitis C virus declining, say researchers

USC University Hospital receives Heart Transplant Excellence Award

Human-derived UCB stem cell transplant has positive therapeutic effects on specific lung and heart disorders

Study: Impaired oxidation in liver associated with progression to nonalcoholic steatohepatitis

Health Heritage: New website for maintaining family's health history

Misconceptions about contraception contribute to lack of family-planning n Uganda

DTCA linked with increased Medicaid pharmacy expenditures

Press Ganey releases 'Patient Perspectives on American Health Care' report

Jubilant Organosys, UAB and Southern Research Institute announce joint venture to accelerate global drug development

Urban sprawl causes delay in ambulances reaching their destinations in the United States

AmKor and Hengdian Group sign license agreement to develop and market new drug candidate in China

10 x '20 Initiative calls for global commitment to develop 10 new antibiotics by 2020

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring